Chemistry Service Platform - CRO in Medicinal Chemistry

Axon Ligands (TM) - alphabetic: [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z]

 

 

 

  

Remogliflozin

GSK 189074

CAS 329045-45-6

C23H34N2O7  MW 450.53

Purity: 99%

 

 

 

 

 

Ordering Information:

 

Cat. No. Axon 1634

 

Qty1: 5 mg / €135  $176

 

Qty2: 25 mg / €485  $631

 

Qty3: on request

 

Send enquiry to: order@axonmedchem.com

or by fax to: +31-50-3600390.

 

Contact us for our product range and services.

Biological Activity:

 

Remogliflozin inhibits the sodium-glucose transport (SGLT2) proteins, which are responsible for glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the urine. Its prodrug is Remoglifozin etabonate (GSK 189075), investigated as a treatment of anti diabetes type II.

 

References: online

 

Y Fujimori et al. Remogliflozin Etabonate, in a Novel Category of Selective Low-Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors, Exhibits Antidiabetic Efficacy in Rodent Models. J. Pharmacol. Exp. Ther. 2008, 327(1), 268-276. [online]

 

 

Chemical Name: (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-(4-isopropoxybenzyl)-1-isopropyl-5-methyl-1H-pyrazol-3-yloxy)tetrahydro-2H-pyran-3,4,5-triol

 

Remogliflozin | SGLT2 inhibitor | Axon Medchem | Axon 1634 | GSK 189074

axonmedchem.com © 2011

 

Axon Ligands in the field:

 

Remogliflozin | SGLT2 inhibitor

 

 

 

Axon Ligands TM

 

Research chemicals for biological study. Some high-profile samples could be provided under terms of contract research synthesis.